Ligand Pharmaceuticals Incorporated (23) | Stock Agreements (2)
- Contingent Value Rights Agreement, dated as of September 30, 2020, by and between Ligand Pharmaceuticals Incorporated and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 6, 2020)
- Amended and Restated Director Compensation and Stock Ownership Policy, effective March 28, 2019 (Filed With SEC on February 27, 2020)
